{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:38Z","timestamp":1790806418996,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00296-019-04300-0","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T09:32:27Z","timestamp":1554975147000},"page":"1107-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adalimumab in the treatment of pediatric Beh\u00e7et\u2019s disease: case-based review"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6431-9334","authenticated-orcid":false,"given":"Dimitri","family":"Poddighe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-6206","authenticated-orcid":false,"given":"Zaure","family":"Mukusheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-9778","authenticated-orcid":false,"given":"Kaisar","family":"Dauyey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-5140","authenticated-orcid":false,"given":"Maikesh","family":"Assylbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,11]]},"reference":[{"key":"4300_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02046-y","author":"E Seyahi","year":"2019","unstructured":"Seyahi E (2019) Phenotypes in Beh\u00e7et\u2019s syndrome. Intern Emerg Med. \n                    https:\/\/doi.org\/10.1007\/s11739-019-02046-y\n                    \n                  \n                           (Epub ahead of print)","journal-title":"Intern Emerg Med"},{"key":"4300_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-4632.2006.02754.x","volume":"45","author":"M Borlu","year":"2006","unstructured":"Borlu M, Uksal U, Ferahbas A, Evereklioglu C (2006) Clinical features of Behcet\u2019s disease in children. Int J Dermatol 45:713\u2013716","journal-title":"Int J Dermatol"},{"key":"4300_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","volume":"58","author":"Y Karincaoglu","year":"2008","unstructured":"Karincaoglu Y, Borlu M, Toker SC et al (2008) Demographic and clinical properties of juvenile-onset Beh\u00e7et\u2019s disease: a controlled multicenter study. J Am Acad Dermatol 58:579\u2013584","journal-title":"J Am Acad Dermatol"},{"key":"4300_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","volume":"43","author":"H Yazici","year":"2012","unstructured":"Yazici H, Ugurlu S, Seyahi E (2012) Beh\u00e7et\u2019s disease, is it one condition? Clinic Rev Allerg Immunol 43:275\u2013280","journal-title":"Clinic Rev Allerg Immunol"},{"key":"4300_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","volume":"14","author":"I Kon\u00e9-Paut","year":"2016","unstructured":"Kon\u00e9-Paut I (2016) Beh\u00e7et\u2019s disease in children, an overview. Pediatr Rheumatol Online J 14:10","journal-title":"Pediatr Rheumatol Online J"},{"key":"4300_CR6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Beh\u00e7et disease. Ann Rheum Dis 67:1656\u20131662","journal-title":"Ann Rheum Dis"},{"key":"4300_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1991-y","author":"G Emmi","year":"2018","unstructured":"Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D (2018) Vascular Beh\u00e7et\u2019s syndrome: an update. Intern Emerg Med. \n                    https:\/\/doi.org\/10.1007\/s11739-018-1991-y\n                    \n                  \n                           (Epub ahead of print)","journal-title":"Intern Emerg Med"},{"key":"4300_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417","journal-title":"Rheumatol Int"},{"key":"4300_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","volume":"75","author":"I Kon\u00e9-Paut","year":"2016","unstructured":"Kon\u00e9-Paut I, Shahram F, Darce-Bello M et al (2016) Consensus classification criteria for paediatric Beh\u00e7et\u2019s disease from a prospective observational cohort: pEDBD. Ann Rheum Dis 75:958\u2013964","journal-title":"Ann Rheum Dis"},{"key":"4300_CR10","doi-asserted-by":"publisher","first-page":"107421","DOI":"10.1155\/2014\/107421","volume":"2014","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Rigante D, Lucherini OM et al (2014) Biological treatments in Beh\u00e7et\u2019s disease: beyond anti-TNF therapy. Mediators Inflamm 2014:107421","journal-title":"Mediators Inflamm"},{"key":"4300_CR11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","volume":"13","author":"D Poddighe","year":"2014","unstructured":"Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL (2014) A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev 13:1142\u20131148","journal-title":"Autoimmun Rev"},{"key":"4300_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.39667","volume":"68","author":"H Vallet","year":"2016","unstructured":"Vallet H, Seve P, Biard L et al (2016) Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French uveitis network. Arthritis Rheumatol 68:1522\u20131530","journal-title":"Arthritis Rheumatol"},{"key":"4300_CR13","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","volume":"53","author":"V Calvo-R\u00edo","year":"2014","unstructured":"Calvo-R\u00edo V, Blanco R, Beltr\u00e1n E et al (2014) Anti-TNF-\u03b1 therapy in patients with refractory uveitis due to Beh\u00e7et\u2019s disease: a 1-year follow-up study of 124 patients. Rheumatology (Oxford) 53:2223\u20132231","journal-title":"Rheumatology (Oxford)"},{"key":"4300_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-016-3417-4","volume":"36","author":"A Vitale","year":"2017","unstructured":"Vitale A, Emmi G, Lopalco G et al (2017) Adalimumab effectiveness in Beh\u00e7et\u2019s disease: short and long-term data from a multicenter retrospective observational study. Clin Rheumatol 36:451\u2013455","journal-title":"Clin Rheumatol"},{"key":"4300_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.cgh.2014.08.042","volume":"13","author":"S Tanida","year":"2015","unstructured":"Tanida S, Inoue N, Kobayashi K et al (2015) Adalimumab for the treatment of Japanese patients with intestinal Beh\u00e7et\u2019s disease. Clin Gastroenterol Hepatol 13:940\u2013948","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4300_CR16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","volume":"125","author":"JL Mart\u00edn-Varillas","year":"2018","unstructured":"Mart\u00edn-Varillas JL, Calvo-R\u00edo V, Beltr\u00e1n E et al (2018) Successful optimization of adalimumab therapy in refractory uveitis due to Beh\u00e7et\u2019s disease. Ophthalmology 125:1444\u20131451","journal-title":"Ophthalmology"},{"key":"4300_CR17","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.2174\/0929867325666180522085716","volume":"25","author":"D Poddighe","year":"2018","unstructured":"Poddighe D, Romano M, Gattinara M, Gerloni V (2018) Biologics for the treatment of juvenile idiopathic arthritis. Curr Med Chem 25:5860\u20135893","journal-title":"Curr Med Chem"},{"key":"4300_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","volume":"15","author":"R Gallizzi","year":"2017","unstructured":"Gallizzi R, Pidone C, Cantarini L et al (2017) A national cohort study on pediatric Beh\u00e7et\u2019s disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J 15:84","journal-title":"Pediatr Rheumatol Online J"},{"key":"4300_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pediatrneurol.2010.04.021","volume":"43","author":"AB Robinson","year":"2010","unstructured":"Robinson AB, Gallentine WB, Rabinovich CE (2010) Pediatric neuro-Beh\u00e7et\u2019s disease responsive to adalimumab. Pediatr Neurol 43:291\u2013293","journal-title":"Pediatr Neurol"},{"key":"4300_CR20","first-page":"S58","volume":"32","author":"E Interlandi","year":"2014","unstructured":"Interlandi E, Leccese P, Olivieri I, Latanza L (2014) Adalimumab for treatment of severe Beh\u00e7et\u2019s uveitis: a retrospective long-term follow-up study. Clin Exp Rheumatol 32:S58\u2013S62","journal-title":"Clin Exp Rheumatol"},{"key":"4300_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/rheumatology\/kev197","volume":"54","author":"I Pagnini","year":"2015","unstructured":"Pagnini I, Bondi T, Simonini G, Giani T, Marino A, Cimaz R (2015) Successful treatment with canakinumab of a paediatric patient with resistant Beh\u00e7et\u2019s disease. Rheumatology (Oxford) 54:1327\u20131328","journal-title":"Rheumatology (Oxford)"},{"key":"4300_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13052-016-0291-2","volume":"42","author":"M Marsili","year":"2016","unstructured":"Marsili M, Marzetti V, Lucantoni M, Lapergola G, Gattorno M, Chiarelli F, Breda L (2016) Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Beh\u00e7et disease responding to adalimumab: a case report. Ital J Pediatr 42:81","journal-title":"Ital J Pediatr"},{"key":"4300_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5217\/ir.2017.15.3.422","volume":"15","author":"KI Lim","year":"2017","unstructured":"Lim KI, Yang DH, Ryoo E (2017) Beh\u00e7et\u2019s disease with multiple splenic abscesses in a child. Intest Res 15:422\u2013428","journal-title":"Intest Res"},{"key":"4300_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","volume":"57","author":"B Atienza-Mateo","year":"2018","unstructured":"Atienza-Mateo B, Calvo-R\u00edo V, Beltr\u00e1n E et al (2018) Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Beh\u00e7et\u2019s disease: multicentre retrospective study. Rheumatology (Oxford) 57:856\u2013864","journal-title":"Rheumatology (Oxford)"},{"key":"4300_CR25","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","volume":"35","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA (2016) Paediatric Beh\u00e7et\u2019s disease: a UK tertiary centre experience. Clin Rheumatol 35:2509\u20132516","journal-title":"Clin Rheumatol"},{"key":"4300_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1546-0096-11-16","volume":"11","author":"G Simonini","year":"2013","unstructured":"Simonini G, Taddio A, Cattalini M et al (2013) Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-\u03b1 therapy in childhood chronic uveitis. Pediatr Rheumatol Online J 11:16","journal-title":"Pediatr Rheumatol Online J"},{"key":"4300_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00417-018-3928-6","volume":"256","author":"I Deitch","year":"2018","unstructured":"Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M (2018) The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies. Graefes Arch Clin Exp Ophthalmol 256:801\u2013808","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04300-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T19:14:36Z","timestamp":1586459676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4300"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04300-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,11]]},"assertion":[{"value":"5 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The guardian and the patient provided informed written consent for this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}